Biotech Values

[gdollasign]

TGTX IR response. Conversation started here:

https://twitter.com/grdollasign/status/524940698349355009


Hi Ross-

We thought you were referring to the Day 15 Plasma Concentration Projections slide which was presented during the BioCentury Conference in September 2013. We checked the presentation posted online for the 2014 Rodman conference and there was a slide, which Mike did not speak to in his presentation nor was it actually presented at the Rodman conference, which shows the Idelalisib Cmax at 150mg BID and the projected trough level for the 800mg QD micronized fed dose of TGR-1202. In the slide posted online from the Rodman presentation it is clearly noted that the comparison is our projected trough level to Idelalisib's Cmax and is not the same as the slide referenced in the article.

Here is the link to the presentation posted by Rodman:
http://wsw.com/webcast/rrshq24/tgtx/

Also, I wanted to note that in June 2014 at the Wells Fargo Healthcare Conference Mike does speak to the slide where we note Idelalisib’s Cmax and speak to our projected trough level. You can view the webcast from the event on our website http://ir.tgtherapeutics.com/events.cfm. If you scroll to the 15 min and 30 second mark of the audio file, Mike clearly explains our position as well as why we think this information is valid and important. He also reviews this slide and information in the JP Morgan January 2014 webcast, also available on the events page of our website.

Hope this helps to clarify.

Best,
Jenna